OTX015, a novel BET inhibitor, is a promising anticancer agent for multiple myeloma

被引：2
|
作者：
Todaro, Maria [1 ,2 ]
Boi, Michela [1 ,2 ]
Vurchio, Valentina [1 ,2 ]
Ercole, Elisabetta [1 ,2 ]
Machiorlatti, Rodolfo [1 ,2 ]
Messana, Katia [1 ,2 ]
Landra, Indira [1 ,2 ]
Urigu, Susanna [1 ,2 ]
Aliberti, Sabrina [1 ,2 ]
Riveiro, Eugenia [3 ]
Bertoni, Francesco [4 ]
Inghirami, Giorgio [5 ]
机构：
[1] Univ Turin, Dept Pathol, Turin, Italy
[2] Univ Turin, Ctr Expt Res & Med Studies CeRMS, Turin, Italy
[3] Oncol Therapeut Dev, Clichy, France
[4] Oncol Res Inst, Bellinzona, Switzerland
[5] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-5531
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5531
引用
收藏
页数：2
相关论文
共 50 条
  • [1] OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, is a promising anticancer agent for human glioblastoma
    Ouafik, L.
    Berenguer, C.
    Cayol, M.
    Astorgues-Xerri, L.
    Bekradda, M.
    Odore, E.
    Rezai, K.
    Riveiro, M. E.
    Cvitkovic, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 153 - 153
  • [2] The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple Myeloma
    Gu, Jie
    Song, Sha
    Han, Huiying
    Xu, Hongxia
    Fan, Gao
    Qian, Chen'ao
    Qiu, Yingchun
    Zhou, Wenqi
    Zhuang, Wenzhuo
    Li, Bingzong
    [J]. MOLECULAR PHARMACEUTICS, 2018, 15 (11) : 5387 - 5396
  • [3] Development of the BET bromodomain inhibitor OTX015
    Noel, J. Kay
    Iwata, Kazunori
    Ooike, Shinsuke
    Sugahara, Kunio
    Nakamura, Hideo
    Daibata, Masanori
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [4] Potent Activity of the Bromodomain Inhibitor OTX015 in Multiple Myeloma
    Shi, Jixiang
    Song, Sha
    Han, Huiying
    Xu, Hongxia
    Huang, Moli
    Qian, Chen'ao
    Zhang, Xiaojuan
    Ouyang, Lu
    Hong, Yating
    Zhuang, Wenzhuo
    Li, Bingzong
    [J]. MOLECULAR PHARMACEUTICS, 2018, 15 (09) : 4139 - 4147
  • [5] The BET bromodomain inhibitor OTX015 shows synergy with several anticancer agents in preclinical models of mantle cell lymphoma (MCL) and multiple myeloma (MM)
    Bernasconi, E.
    Tarantelli, C.
    Gaudio, E.
    Kwee, I.
    Stathis, A.
    Riveiro, E.
    Herait, P.
    Cvitkovic, E.
    Zucca, E.
    Bertoni, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 184 - 184
  • [6] Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts
    Vazquez, Ramiro
    Licandro, Simonetta Andrea
    Astorgues-Xerri, Lucile
    Lettera, Emanuele
    Panini, Nicolo
    Romano, Michela
    Erba, Eugenio
    Ubezio, Paolo
    Bello, Ezia
    Libener, Roberta
    Orecchia, Sara
    Grosso, Federica
    Riveiro, Maria Eugenia
    Cvitkovic, Esteban
    Bekradda, Mohamed
    D'Incalci, Maurizio
    Frapolli, Roberta
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (01) : 197 - 207
  • [7] BET inhibitor OTX015 reduces imiquimod- induced mouse psoriasiform dermatitis
    Wu, X.
    Yu, S.
    Shi, Z.
    Huynh, M.
    Chong, J.
    Hwang, S. T.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S119 - S119
  • [8] Targeting prostate cancer stem cells (CSCs) with the novel BET bromodomain (BRD) protein inhibitor OTX015
    Civenni, Gianluca
    Pedrani, Silvia
    Allegrini, Sara
    Bruccoleri, Antonina
    Albino, Domenico
    Pinton, Sandra
    Garcia-Escudero, Ramon
    Ouafik, L'Houcine
    Cvitkovic, Esteban
    Carbone, Giuseppina M.
    Catapano, Carlo V.
    [J]. CANCER RESEARCH, 2015, 75
  • [9] BET inhibitor OTX015 suppresses gastric cancer through pharmacology and promotion of the immune response
    Xu, Guanghuan
    Kai, Yin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (06): : 3945 - 3954
  • [10] OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, displays antitumoral effects in orthotopic and heterotopic models of human glioblastoma
    Astorgues-xerri, Lucile
    Berenger, Caroline
    Cayol, Mylene
    Bekradda, Mohamed
    Odore, Elodie
    Rezai, Keyvan
    Cvitkovic, Esteban
    Riveiro, Maria E.
    Ouafik, L'Houcine
    [J]. CANCER RESEARCH, 2015, 75
12345